Perhaps China decided to make its own version of the drug or perhaps it proved that it could do so…
Australian pharmaceuticals company Medical Developments (ASX: MVP) is set to renew their international expansion targets with greater control having taken…
Australian pharmaceuticals manufacturer Medical Developments International (ASX: MVP) has secured approval from the Chinese National Medical Product Administration (NMPA) to…